GMAB:CPH
Genmab
2.324,00 DKK
arrow_downward
-0,81%(-19,00) 1 d
1 oct, 11:07:33 GMT+2 · DKK
search
Todos los símbolos
| Símbolo | Precio | Cambio | % de cambio |
|---|
insights_autoGenerando estadísticas principales de GMAB...
Abrir
2.339,00 DKK
Alto
2.346,00 DKK
Bajo
2.309,00 DKK
Cap. burs.
144,96 mil M
Vol. medio
112,03 mil
Volumen
21,75 mil
Máximo en 52 sem.
2.359,00 DKK
Mínimo en 52 sem.
1.512,00 DKK
Acciones en circulación
62,41 M
N.º de empleados
3 mil
Abrir
2.339,00 DKK
Alto
2.346,00 DKK
Bajo
2.309,00 DKK
Cap. burs.
144,96 mil M
Vol. medio
112,03 mil
Volumen
21,75 mil
Máximo en 52 sem.
2.359,00 DKK
Mínimo en 52 sem.
1.512,00 DKK
Acciones en circulación
62,41 M
N.º de empleados
3 mil
Noticias
De fuentes web y partners de noticias
AD HOC NEWS
·
hace 19 horas
MRUS stock ends after Genmab completes its acquisition
TipRanks
·
hace 1 día
Genmab Updates Capital Structure and Articles of Association in September 2026 SEC Filing
AD HOC NEWS
·
hace 2 días
Genmab stock reflects higher 2026 revenue guidance
Perfil
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
Acerca de Genmab